Gullimex attracts investor Holland Capital for further growth
Borne / Amsterdam, 10th of March 2025 – Investment firm Holland Capital is investing in Gullimex, a strong player in measurement, quality, and control solutions within the food and medical sectors. Holland Capital’s investment provides Gullimex the opportunity to realize its growth ambitions.
Growing quality standards
The importance of food safety, patient safety, and hygiene continues to grow in a market characterized by increasingly stringent regulations and rising expectations regarding quality and efficiency. Gullimex supports businesses and institutions in navigating this dynamic and demanding environment, optimizing their processes through its role as an advisor, premium brand supplier, and service partner.
Gullimex ensures consistent quality measurements, optimal hygiene, and safe production within mission-critical processes. The company achieves this through an integrated combination of hardware, software, and services, providing customers with solutions that directly address the specific needs and challenges of the food and medical sectors.
Investment for growth
Gullimex aims to become the leading European provider of measurement, quality, and control solutions, leveraging data to create value for the food and medical industries. With Holland Capital’s investment, the company can achieve its growth ambitions both organically and through strategic acquisitions.
Maarten Snijders, Investment Director AgriFood-Tech at Holland Capital, said: “We are proud to support Gullimex in achieving its ambitions. As an investor with years of experience in Tech, AgriFood, and Healthcare, we aim to contribute to Gullimex’s international growth and its mission to create even more value for all its partners.”
Lucien Kwakkel, CEO of Gullimex, added: “We value Holland Capital as a strategic partner that not only invests in our growth but also actively supports us with expertise, experience, a strong network, and a hands-on mentality. Thanks to their experience and vision, we can further strengthen our position in key markets and accelerate our ambitions both nationally and internationally.”
About Gullimex
Founded in 1981, Gullimex supports a large customer base within the food and medical sectors with measurement and data recording solutions. The team of 60+ experts is active in the fields of food safety, patient safety, and hygiene. Gullimex has offices in the Netherlands, Belgium, and Germany.
About Holland Capital
For over 40 years, Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions. The team understands entrepreneurship and strives for an open, sustainable, and professional relationship with the management teams of the companies in which it invests, with the common goal of achieving growth. Holland Capital has offices in Amsterdam and Düsseldorf. With its specialized sector teams, the firm focuses on Healthcare, Technology, and AgriFood-Tech. It understands the dynamics and opportunities within these sectors and has an extensive network.
Magnus Energy en Ciratum bundelen krachten en nemen het voortouw in de energietransitie
Adviesbureaus Magnus Energy en Ciratum bundelen hun krachten om hun dienstverlening te versterken en te verbreden. Om zo innovatieve, hoogwaardige en holistische oplossingen te bieden aan Nederlandse klanten in de energiesector.
Guiding the energy transition: Magnus Energy and Ciratum unite to lead the way
Magnus Energy and Ciratum have joined forces to elevate their service offerings, delivering innovative, high-quality, and holistic solutions to Dutch customers in the energy sector.
Uman raises EUR 1.9m from Holland Capital to disrupt sales enablement market
Uman, the Belgium-based AI-driven software platform for B2B sales teams, raises 1.9 million euros. The funding round is led by Holland Capital, together with existing investors imec and Seeder Fund.
Gentse AI start-up die de perfecte sales pitch genereert, haalt 1,9 miljoen euro op bij Holland Capital
Uman, het Gentse AI-gedreven softwareplatform voor B2B sales teams, haalt 1,9 miljoen euro op. De financieringsronde wordt geleid door Holland Capital, in combinatie met bestaande investeerders imec en Seeder Fund.
Holland Capital kondigt succesvolle exit van Defibrion aan IK Partners aan
Sinds 2019 heeft het management team van Defibrion op succesvolle wijze samengewerkt met Holland Capital. De aandelen van Defibrion worden verkocht aan IK en Defibrion’s management team.
Holland Capital Announces Successful Exit of Defibrion to IK Partners
Since 2019, Defibrion’s management team has successfully collaborated with Holland Capital. The shares of Defibrion are being sold to IK and the company’s management team.
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl



